Changes in apparent diffusion coefficient and pathological response in colorectal liver metastases after preoperative chemotherapy

Abstract

Background

The pathological response to preoperative chemotherapy of colorectal liver metastases (CRLMs) is predictive of long-term prognosis after liver resection. Accurate preoperative assessment of chemotherapy response could enable treatment optimization.

Purpose

To investigate whether changes in lesion-apparent diffusion coefficient (ADC) measured with diffusion-weighted magnetic resonance imaging (MRI) can be used to assess pathological treatment response in patients with CRLMs undergoing preoperative chemotherapy.

Material and Methods

Patients who underwent liver resection for CRLMs after preoperative chemotherapy between January 2011 and December 2019 were retrospectively included if they had undergone MRI before and after preoperative chemotherapy on the same 1.5-T MRI scanner with diffusion-weighted imaging with b-values 50, 400, and 800 s/mm². The pathological chemotherapy response was assessed using the tumor regression grade (TRG) by AJCC/CAP. Lesions were divided into two groups: pathological responding (TRG 0–2) and non-responding (TRG 3). The change in lesion ADC after preoperative chemotherapy was compared between responding and non-responding lesions.

Results

A total of 27 patients with 49 CRLMs were included, and 24/49 lesions showed a pathological chemotherapy response. After chemotherapy, ADC increased in both pathological responding (pretreatment ADC: 1.26 [95% confidence interval (CI)=1.06–1.37] vs. post-treatment ADC: 1.33 [95% CI=1.13–1.56] × 10⁻³ mm²/s; P = 0.026) and non-responding lesions (1.12 [95% CI=0.980–1.21] vs. 1.20 [95% CI=1.09–1.43] × 10⁻³ mm²/s; P = 0.018). There was no difference in median relative difference in ADC after chemotherapy between pathological responding and non-responding lesions (15.8 [95% CI=1.42–26.3] vs. 7.17 [95% CI=−4.31 to 31.2]%; P = 0.795).

Conclusion

Changes in CRLM ADCs did not differ between pathological responding and non-responding lesions.

Keywords

Colorectal liver metastases preoperative chemotherapy magnetic resonance diffusion liver pathology surgery

Get full access to this article

View all access options for this article.

References

Rubbia-Brandt

Giostra

Brezault

, et al. Importance of histological tumor response assessment in predicting the outcome in patients with colorectal liver metastases treated with neo-adjuvant chemotherapy followed by liver surgery. Ann Oncol 2007;18:299–304.

Adam

Wicherts

de Haas

, et al.

Complete pathologic response after preoperative chemotherapy for colorectal liver metastases: myth or reality?

J Clin Oncol 2008;26:1635–1641.

Blazer

III Kishi

Maru

, et al. Pathologic response to preoperative chemotherapy: a new outcome end point after resection of hepatic colorectal metastases. J Clin Oncol 2008;26:5344–5351.

Eisenhauer

Therasse

Bogaerts

, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 2009;45:228–247.

Shindoh

Loyer

Kopetz

, et al. Optimal morphologic response to preoperative chemotherapy: an alternate outcome end point before resection of hepatic colorectal metastases. J Clin Oncol 2012;30:4566–4572.

Vera

Gomez Dorronsoro

Lopez-Ben

, et al. Retrospective analysis of pathological response in colorectal cancer liver metastases following treatment with bevacizumab. Clin Transl Oncol 2014;16:739–745.

Brouquet

Blot

Allard

, et al.

What is the prognostic value of a discordant radiologic and pathologic response in patients undergoing resection of colorectal liver metastases after preoperative chemotherapy?

Ann Surg Oncol 2020;27:2877–2885.

Vilgrain

Esvan

Ronot

, et al. A meta-analysis of diffusion-weighted and gadoxetic acid-enhanced MR imaging for the detection of liver metastases. Eur Radiol 2016;26:4595–4615.

Cui

Zhang

Sun

, et al. Apparent diffusion coefficient: potential imaging biomarker for prediction and early detection of response to chemotherapy in hepatic metastases. Radiology 2008;248:894–900.

10.

Kauppinen

. Monitoring cytotoxic tumour treatment response by diffusion magnetic resonance imaging and proton spectroscopy. NMR Biomed 2002;15:6–17.

11.

Koh

Collins

. Diffusion-weighted MRI in the body: applications and challenges in oncology. AJR Am J Roentgenol 2007;188:1622–1635.

12.

Heijmen

Ter Voert

Nagtegaal

, et al. Diffusion-weighted MR imaging in liver metastases of colorectal cancer: reproducibility and biological validation. Eur Radiol 2013;23:748–756.

13.

Zhang

Sun

Tang

, et al. Correlation of diffusion-weighted imaging data with apoptotic and proliferation indexes in CT26 colorectal tumor homografts in balb/c mouse. J Magn Reson Imaging 2011;33:1171–1176.

14.

Koh

Scurr

Collins

, et al. Predicting response of colorectal hepatic metastasis: value of pretreatment apparent diffusion coefficients. AJR Am J Roentgenol 2007;188:1001–1008.

15.

Tam

Collins

Brown

, et al. The role of pre-treatment diffusion-weighted MRI in predicting long-term outcome of colorectal liver metastasis. Br J Radiol 2013;86:20130281.

16.

Wagner

Ronot

Doblas

, et al. Assessment of the residual tumour of colorectal liver metastases after chemotherapy: diffusion-weighted MR magnetic resonance imaging in the peripheral and entire tumour. Eur Radiol 2016;26:206–215.

17.

Donati

Boraschi

Pacciardi

, et al. 3T diffusion-weighted MRI in the response assessment of colorectal liver metastases after chemotherapy: correlation between ADC value and histological tumour regression grading. Eur J Radiol 2017;91:57–65.

18.

Hosseini-Nik

Fischer

Moulton

, et al. Diffusion-weighted and hepatobiliary phase gadoxetic acid-enhanced quantitative MR imaging for identification of complete pathologic response in colorectal liver metastases after preoperative chemotherapy. Abdom Radiol (NY) 2016;41:231–238.

19.

Donati

Chong

Nanz

, et al. Diffusion-weighted MR imaging of upper abdominal organs: field strength and intervendor variability of apparent diffusion coefficients. Radiology 2014;270:454–463.

20.

Winfield

Collins

Priest

, et al. A framework for optimization of diffusion-weighted MRI protocols for large field-of-view abdominal-pelvic imaging in multicenter studies. Med Phys 2016;43:95.

21.

Malyarenko

Galbán

Londy

, et al. Multi-system repeatability and reproducibility of apparent diffusion coefficient measurement using an ice-water phantom. J Magn Reson Imaging 2013;37:1238–1246.

22.

Dale

Braithwaite

Boll

, et al. Field strength and diffusion encoding technique affect the apparent diffusion coefficient measurements in diffusion-weighted imaging of the abdomen. Invest Radiol 2010;45:104–108.

23.

Winfield

deSouza

Priest

, et al. Modelling DW-MRI data from primary and metastatic ovarian tumours. Eur Radiol 2015;25:2033–2040.

24.

Schmeel

. Variability in quantitative diffusion-weighted MR imaging (DWI) across different scanners and imaging sites: is there a potential consensus that can help reducing the limits of expected bias? Eur Radiol 2019;29:2243–2245.

25.

Boraschi

Donati

Cervelli

, et al. Colorectal liver metastases: ADC as an imaging biomarker of tumor behavior and therapeutic response. Eur J Radiol 2021;137:109609.

26.

Liu

Zhou

, et al. Identifying response in colorectal liver metastases treated with bevacizumab: development of RECIST by combining contrast-enhanced and diffusion-weighted MRI. Eur Radiol 2021;31:5640–5649.

27.

Blind PJ, Andersson B, Tingstedt B, et al. Fast-track program for liver resection–factors prolonging length of stay. Hepato-gastroenterology 2014;61:2340–2344.

28.

Amin

Edge

Greene

, et al. AJCC Cancer staging manual. 8th ed. New York: Springer International Publishing, 2017.

29.

Adam

Pascal

Castaing

, et al.

Tumor progression while on chemotherapy: a contraindication to liver resection for multiple colorectal metastases?

Ann Surg 2004;240:1052–1061; discussion 1061–1054.

30.

Vigano

Capussotti

Barroso

, et al. Progression while receiving preoperative chemotherapy should not be an absolute contraindication to liver resection for colorectal metastases. Ann Surg Oncol 2012;19:2786–2796.

31.

Paulatto

Dioguardi Burgio

Sartoris

, et al. Colorectal liver metastases: radiopathological correlation. Insights Imaging 2020;11:99.

32.

Schmeel

Simon

Sabet

, et al. Diffusion-weighted magnetic resonance imaging predicts survival in patients with liver-predominant metastatic colorectal cancer shortly after selective internal radiation therapy. Eur Radiol 2017;27:966–975.

33.

Chiaradia

Baranes

Van Nhieu

, et al.

Intravoxel incoherent motion (IVIM) MR imaging of colorectal liver metastases: are we only looking at tumor necrosis?

J Magn Reson Imaging 2014;39:317–325.

34.

Poultsides

Bao

Servais

, et al. Pathologic response to preoperative chemotherapy in colorectal liver metastases: fibrosis, not necrosis, predicts outcome. Ann Surg Oncol 2012;19:2797–2804.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.03 MB